These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28237048)

  • 21. Thirty- Versus Ten-Day Diazepam Treatment for Alcohol Detoxification and a Comparison of Drinking Patterns, Craving, and Anxiety for up to 12 Weeks: A "Proof-of-Concept" Open-Label Randomized Controlled Trial.
    Simioni N; Labreuche J; Behal H; Cottencin O; Rolland B
    J Clin Psychopharmacol; 2017 Dec; 37(6):722-728. PubMed ID: 28984747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment.
    Witkiewitz K; Kirouac M; Roos CR; Wilson AD; Hallgren KA; Bravo AJ; Montes KS; Maisto SA
    Psychol Addict Behav; 2018 Sep; 32(6):639-646. PubMed ID: 30160499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Hypothesized Mechanisms of Change Before and After Initiating Abstinence in Cognitive-Behavioral Therapy for Women With Alcohol Use Disorder.
    Hallgren KA; Epstein EE; McCrady BS
    Behav Ther; 2019 Nov; 50(6):1030-1041. PubMed ID: 31735239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do Social Cognition Deficits Recover with Abstinence in Alcohol-Dependent Patients?
    Rupp CI; Junker D; Kemmler G; Mangweth-Matzek B; Derntl B
    Alcohol Clin Exp Res; 2021 Feb; 45(2):470-479. PubMed ID: 33523497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol expectancies pre-and post-alcohol use disorder treatment: Clinical implications.
    Coates JM; Gullo MJ; Feeney GFX; Young RM; Dingle GA; Connor JP
    Addict Behav; 2018 May; 80():142-149. PubMed ID: 29407685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Are Self-Efficacy and Motivation Related to Drinking Five Years after Residential Treatment? A Longitudinal Multicenter Study.
    Müller A; Znoj H; Moggi F
    Eur Addict Res; 2019; 25(5):213-223. PubMed ID: 31112984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in Project MATCH when dependence severity is high.
    Roos CR; Maisto SA; Witkiewitz K
    Addiction; 2017 Sep; 112(9):1547-1557. PubMed ID: 28388836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining the daily reciprocal relations between alcohol abstinence self-efficacy and drinking among non-treatment seeking individuals with alcohol use disorder (AUD).
    Walsh BE; Manzler CA; Noyes ET; Schlauch RC
    Addict Behav; 2024 Sep; 156():108068. PubMed ID: 38772225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breathalyser-Based eHealth Data Suggest That Self-Reporting of Abstinence Is a Poor Outcome Measure for Alcohol Use Disorder Clinical Trials.
    Hämäläinen MD; Zetterström A; Winkvist M; Söderquist M; Öhagen P; Andersson K; Nyberg F
    Alcohol Alcohol; 2020 Apr; 55(3):237-245. PubMed ID: 32118260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drop-out, relapse and abstinence in a cohort of alcoholic people under detoxification.
    Ledda R; Battagliese G; Attilia F; Rotondo C; Pisciotta F; Gencarelli S; Greco A; Fiore M; Ceccanti M; Attilia ML
    Physiol Behav; 2019 Jan; 198():67-75. PubMed ID: 30336230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drinking Goal Trajectories and Their Association with Client Characteristics and Outcomes among Clients in Outpatient Alcohol Treatment.
    Haug S; Castro RP; Eggli P; Schaub MP
    Subst Use Misuse; 2018 Nov; 53(13):2140-2151. PubMed ID: 29652560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment response and non-response in CBT and Network Support for alcohol disorders: targeted mechanisms and common factors.
    Litt MD; Kadden RM; Tennen H
    Addiction; 2018 Aug; 113(8):1407-1417. PubMed ID: 29575339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of individual versus group female-specific cognitive behavioral therapy for alcohol use disorder.
    Olmstead TA; Graff FS; Ames-Sikora A; McCrady BS; Gaba A; Epstein EE
    J Subst Abuse Treat; 2019 May; 100():1-7. PubMed ID: 30898323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Neuropsychological Status during the Initial Phase of Abstinence in Alcohol Use Disorder: Neurocognitive Impairment and Implications for Clinical Care.
    Mulhauser K; Weinstock J; Ruppert P; Benware J
    Subst Use Misuse; 2018 May; 53(6):881-890. PubMed ID: 29293037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapist and client discussions of drinking and coping: a sequential analysis of therapy dialogues in three evidence-based alcohol use disorder treatments.
    Magill M; Walthers J; Mastroleo NR; Gaume J; Longabaugh R; Apodaca TR
    Addiction; 2016 Jun; 111(6):1011-20. PubMed ID: 26780564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya.
    Papas RK; Sidle JE; Gakinya BN; Baliddawa JB; Martino S; Mwaniki MM; Songole R; Omolo OE; Kamanda AM; Ayuku DO; Ojwang C; Owino-Ong'or WD; Harrington M; Bryant KJ; Carroll KM; Justice AC; Hogan JW; Maisto SA
    Addiction; 2011 Dec; 106(12):2156-66. PubMed ID: 21631622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Therapist Feedback on the Therapeutic Alliance and Alcohol Use Outcomes in the Outpatient Treatment of Alcohol Use Disorder.
    Maisto SA; Schlauch RC; Connors GJ; Dearing RL; O'Hern KA
    Alcohol Clin Exp Res; 2020 Apr; 44(4):960-972. PubMed ID: 32020621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.
    Mellinger JL; Scott Winder G; DeJonckheere M; Fontana RJ; Volk ML; Lok ASF; Blow FC
    J Subst Abuse Treat; 2018 Aug; 91():20-27. PubMed ID: 29910011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.